Cryopreserved allografts have demonstrated resistance to infection similar to that of autogenous tissue when used for the treatment of prosthetic arterial bypass graft infections. As the number of hemodialysis access procedures increases, prosthetic hemodialysis graft infection has become a significant problem. We have used the cryopreserved femoral vein as an alternative conduit in the treatment of prosthetic arteriovenous (AV) hemodialysis graft infections. Forty-eight cryopreserved femoral vein AV graft procedures were performed. The 1-year primary graft patency rate was 49%, while the secondary graft patency rate was 75%. No subsequent cryopreserved allograft infections occurred. The cryopreserved femoral vein graft is a safe, durable, and infection resistant conduit for the treatment of prosthetic AV hemodialysis graft infections.
Carrel, A.Ultimate results of aortic transplantations. J Expt Med1912;15:389-392
2.
Szilagyi DE, McDonald RT, Smith BF, Whitcomb JGBiologic fate of human arterial homografts. Arch Surg1957;75:506-529
3.
Szilagyi, DE , Rodriguez FJ, Smith RF, Elliott JPLate fate of arterial allografts: Observations 6 to 15 years after implantation. Arch Surg1970;101:721-733
4.
Moore WS, Swanson, RJ, Campagna G., Bean B.The use of fresh tissue arterial substitutes in infected fields. J Surg Res1975;18:229-233
5.
Koskas F., Goëau-Brissonniere O., Nicolas MH, Bacourt F., Kieffer E.Arteries from human beings are less infectible by Staphlococcus aureus than polytetrafluoroethylene in an aortic dog model. J Vasc Surg1996;23:472-476
6.
Knosalla C., Goëau-Brissonniere O., Leflon V., et al. Treatment of Vascular graft infection by in situ replacement with cryopreserved aortic allografts: An experimental study. J Vasc Surg1998;27:689-698
7.
Vogt PR, Brunner-La Rocca HP, Carrel T., et al. Cryopreserved arterial allografts in the treatment of major vascular infection: A comparison with conventional techniques. J Thorac Cardiovasc Surg1998;116:965-972
8.
Locati P., Novali C., Socrate AM, et al. The use of arterial allografts in aortic graft infections: A three year experience on eighteen patients. J Cardiovasc Surg1998;39:735-741
9.
Bracale GC, Porcellini M., Bernardo B., Bauleo A., Capasso R.Arterial homografts in the management of infected axillofemoral prosthetic grafts. J Cardiovasc Surg1999;40: 271-274
10.
Desgranges P., Beaujan F., Brunet S., et al. Cryopreserved arterial allografts used for the treatment of infected vascular grafts. Ann Vasc Surg1998;12:583-588
11.
Chiesa R., Astore D., Piccolo G., et al. Fresh and cryopreserved arterial homografts in the treatment of prosthetic graft infections: Experience of the Italian collaborative vascular homograft group. Ann Vasc Surg1998;12:457-462
12.
Snyder SO, Wheeler JR, Gregory RT, Gayle RG, Kirkle PKFreshly harvested cadaveric venous homografts as arterial conduits in infected fields. Surgery1987;101:283-291
13.
Fujitani RM , Bassiouny HS, Gewertz BL, Glagov S., Zarins CKCryopreserved saphenous vein allogenic homografts: An alternative conduit in lower extremity arterial reconstruction in infected fields. J Vasc Surg1992;15:519-526
14.
Baraldi A., Bonucchi D., Di Felice A., et al. Liquid nitrogen snap frozen saphenous vein for vascular access in dialysis. ASAIO Transactions1991;37:M225-M227
15.
The USRDS 1996 annual data report. Am J Kid Dis1996;28:S1-S165
16.
Schwab S., Besarab A., Beathard G., et al. Clinical practice guidelines for vascular access. National Kidney Foundation, Dialysis Outcomes Quality Initiative. New York, NY: National Kidney Foundation, Inc; 1997:15-33
17.
Matsuura JH, Johansen KH, Rosenthal D., Clark MD, Clarke KA, Kirby LBCryopreserved femoral vein grafts for difficult hemodialysis access . Ann Vasc Surg2000;14:50-55
18.
Carpenter JP , Tomaszewski JEImmunosuppression for human saphenous vein allograft bypass surgery: A prospective randomized trial. J Vasc Surg1997;26:32-42
Lentz BJ, Veldenz HC, Dennis JW, Khansarinia S., Atteberry LRA three year follow-up on standard versus thin wall ePTFE grafts for hemodialysis . J Vasc Surg1998;28:464-470
21.
Turnbull RG , Lewis GM, Karim MA, et al. Primary vascular access for chronic hemodialysis: A comparison of arteriovenous fistulae with PTFE grafts. Vasc Surg1999;33:51-57
22.
Matsuura JH, Rosenthal D., Clarke K., Knoepp LP, Clark MDCost comparison of cryovein versus graft excision in treating infected hemodialysis grafts Unpublished data
